<DOC>
	<DOCNO>NCT02213835</DOCNO>
	<brief_summary>The aim study determine tolerability potential efficacy dietary therapy , Specific Carbohydrate Diet ( SCD ) , pediatric patient Crohn 's disease ( CD ) Ulcerative Colitis ( UC ) . This single center , open label study design determine tolerability , preliminary safety potential efficacy pediatric patient CD UC . The study patient recruit Seattle Children 's GI clinic . investigator enroll 10 patient mild moderate CD ( define PCDAI score 10-29 ) Ulcerative colitis ( PUCAI 10-60 ) age 8 21 year . Each patient study approximately 12 week .</brief_summary>
	<brief_title>Treatment With Specific Carbohydrate Diet Children With Active Crohns Disease Ulcerative Colitis</brief_title>
	<detailed_description>Ten patient CD UC mild moderate disease activity define Pediatric Crohn 's disease activity index ( PCDAI score 10-29 PUCAI 10 - 60 ) age 8 -21 year enroll study . Each patient receive initial evaluation include physical exam , medication review , nutritional guidance post treatment evaluation . Initial evaluation : Study subject recipient follow lab test include CBC differential &amp; platelet , c-reactive protein , sedimentation rate , albumin , vitamin D level , stool study c. difficile , bacterial culture ovum parasite , stool calprotectin microbiome . Additionally , investigator complete physical exam document current medication . The study nutritionist complete thorough diet history . Treatment : The treatment study Specific Carbohydrate diet ( SCD ) . Intervention base upon standard dietary therapy well nutritional handbook develop Gastroenterology division . Patients receive one-on-one guidance Seattle Children 's Dietician train SCD visit . Prior visit patient fill 3 day nutrition log review dietician clinic visit . Each patient receive book SCD therapy include recipe information diet The two book give include `` Breaking Vicious Cycle '' Elaine Gottschall `` Recipes Specific Carbohydrate Diet '' Raman Prasad . Follow-up : Each study subject clinical follow-up 2 week , 4 week , 8 week 12weeks . Standardized questionnaire , include Pediatric Crohn 's disease activity index ( PCDAI ) Pediatric Ulcerative colitis activity index ( PUCAI ) complete study visit . Information tabulate PCDAI/PUCAI score list Appendix A . In addition patient physical exam standard blood work include CBC , sedimentation rate , C-reactive protein , albumin stool microbiome analysis follow visit . This stool send University Washington ( Dr. Sam Miller 's lab ) analysis . Stool calprotectin additionally do week 4 12 . Vitamin D level measure week 12 . Finally , patient meet nutritionist visit complete thorough diet review . Any question SCD address visit . All study relate information store RedCap database . Participant data study store electronically REDCap platform . The REDCap platform manage Institute Clinical Translational Science University Washington . Only IRB approve research team member access REDCap data platform . Each team member grant access REDCap data system secure login . The information participant de-identified use unique study code . Some personal information date birth store RedCap . Microbiome : Some stool participant screen , week 2 , 4 , 8 12 store microbiome analysis . The sample store Seattle Children 's Hospital Clinical Research Center lab -80 freezer . These sample send University Washington microbiome analysis storage necessary basis . Each sample de-identified label unique study code visit number . Consent storage part Informed Consent process .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1 . Children adolescent eight twenty one year old 2 . Diagnosis Ulcerative colitis Crohn 's Disease make primary gastroenterologist base upon history , physical exam , laboratory/radiological study gastrointestinal histology 3 . Mild moderate disease activity base upon PCDAI score ( 1045 ) PUCAI score ( 1060 ) 4 . Parent/guardian child must able comprehend consent assent 5 . Parent/guardian participant must able attend study visit baseline , week +2 , +4 , +8 , +12 . 6 . Patient must medication change his/her inflammatory bowel disease medication least 1 month , unless medically necessary . 1 . Severe disease PCDAI &gt; 45 PUCAI &gt; 60 2 . Active history intraabdominal abscess , intraabdominal fistula , stricturing Crohn 's disease 3 . Other serious medical condition neurological , liver , kidney , autoimmune systemic disease . 4 . Has begin TNF inhibitor within two month prior study 5 . Has change maintenance medication within last month 6 . Tobacco , alcohol illicit drug abuse 7 . Pregnant subject recipient exclude</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Crohn 's disease Ulcerative colitis</keyword>
</DOC>